Press release
Directive 2004/27/EC - status of the national implementation in Europe
- What does the national implementation look like right now?
- What is the actual regulatory framework in Germany, France, Poland, The Netherlands and Sweden?
FORUM Institute of Management organises an international conference addressing among others these questions.
Seven European experts will discuss the essential topics of the
Directive 2004/27/EC and thus, inform on the current national framework
in Europe.
The conference will take place on 28 March 2006 in Cologne.
For further details please check
http://www.forum-institut.de/sites/veranstaltung.asp?SemNr=0603235
or contact:
Dr. Henriette Wolf-Klein
Deputy head Pharma
FORUM Institute of Management, Heidelberg
Vangerowstraße 18
69115 Heidelberg
Tel. 0049 6221 500 680
Fax. 0049 6221 500 618
h.wolf-klein@forum-institut.de
FORUM Institute is very active and acknowledged in the field of educational seminars and conferences for the pharmaceutical industry. In several areas FORUM has the leading market position. Especially the close co-operation with the regulatory authorities assures the outstanding quality and up-to-dateness of the trainings. Each novel important guideline from the national authorities or the EMEA/CPMP results in a seminar within a short period of time to insure that pharmaceutical industry personnel receives the proper information and training. The speakers are experts from the pharmaceutical industry, service provider, lawyers and national / international authorities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Directive 2004/27/EC - status of the national implementation in Europe here
News-ID: 4240 • Views: …
More Releases from FORUM Institute of Management
Step by step through Medical Device Law
Which laws apply to a clinical trial by medical devices? Which forms of advertising are permitted? Under which circumstances is the manufacturer liable? And when is the user? The current 4th amendment of the German Medical Device Act (MPG) and the associated new requirements for manufacturers. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of discussions.
FORUM Institute fuer Management,…
Quality Documentation of Medicinal Substances incorporated in Medical Devices
In order to demonstrate appropriate quality for incorporated medicinal substances in medical devices (ancillary medicinal substances), applicants need to provide information and scientific data, which are similar to that requested by authorithies for API"s in medicinal products. These data are submitted to the competent authorities by the notified body involved. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of…
The safety inspector for medical device
Every medical device company had to reappoint somebody to the safety inspector of medical devices. This positon comprised a great accountability with personal liability in the field of the company and also to the user. The safety inspector for medical device is bound to procedural requirements. The postion proceed an important role in the risk management. Das FORUM Institut für Management extend to this tender subject an…
Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT
For the first time, all "advanced therapies" (gene therapy, somatic cell therapy and tissue engineering products) will be centralised in a single procedure of the newly adopted European Regulation No 1394/2007 ("the Regulation") on advanced therapy medicinal products (ATMPs). This regulation lays down specific
rules concerning the authorisation, supervision and pharmacovigilance of ATMPs and will apply as of 30 December 2008.
The focus of this seminar will be on the required legitimate…
More Releases for Directive
Comments on an Impact Assessment of EcoDesign Directive
Concerning the energy efficiency of Electric Hand Dryers
The complete Statement, eHA turned in at EC, has been transformed into a broader Position Paper: Please find the Position Paper here on our Web-Site: https://handdryerassociation.org/positions/
Bruxelles/Overseas – The electric Handdryer Association (eHA), the official body that represents the global hand dryer industry, shares its key arguments regarding potential legislative measures resulting of the EcoDesign Directive when it comes to energy efficiency aspect and…
Phenol Restricted Under European Toy Safety Directive
The European Union (EU) has published new restrictions on the use of phenol (CAS 108-95-2) in toys falling under Appendix C of Annex II in Directive 2009/48/EC, the so-called European Toy Safety Directive (TSD). Issued on May 4, 2017, Directive (EU) 2017/774 establishes two sets of limits for phenol:
• No more than 5 mg/L for migration from polymeric materials
• No more than 10 mg/kg for content when used as a preservative
These…
FBDi reminds on EU Directive on Electromagnetic Fields
Bad Birnbach, Germany, June 24, 2016 - The EU member states are required to implement EU occupational health & safety directive 2013/35/EU on electromagnetic fields in national law no later than 1 July 2016. Directive 2013/35/EU defines minimum regulations for the protection of the health & safety of employees from hazards presented by electromagnetic fields (EMF), thereby avoiding unnecessary burdens and costs – especially for small and medium-sized enterprises. FBDi…
Amendment of EU WEEE Directive is Agreed
EU Directive 2002/96/EC came into force in 2003 to regulate the handling of waste electrical and electronic equipment (WEEE). The goals of the Directive are to reduce environmental impact from the disposal of electrical and electronics (E&E) products and promote special collection and recycling of these materials. Producers placing E&E products on the market are required by the Directive to protect the environment by funding their safe disposal.
After nine years…
AAA Supports Alternative Investment Directive
Alternative Asset Analysis (AAA) has spoken out in support of the draft measures for Europe’s Alternative Investment Fund Managers (AIFM) directive.
Boston, MA, August 22, 2011 -- Alternative Asset Analysis (AAA) has spoken out in support of the draft measures for Europe’s Alternative Investment Fund Managers (AIFM) directive.
The trade body for the alternative market in Europe, Efama, said the rules published by the European Securities and Markets Authority (Esma) last month…
New EU Toy Directive Focuses on Strict Product Documentation
Awaiting implementation in July 2011, the new EU 2009/48/EC Toy Safety Directive (TSD) realises the European Parliament demand for greater technical documentation and further responsibilities for toy manufacturers and importers.
Manufacturers to Shoulder Toy Responsibilities
The EU 2009/48/EC Toy Directive includes greater technical documentation responsibilities, including the requirement that manufacturers draft an EC declaration of conformity (DoC) for each product they release in the European market. In addition, manufacturers must keep each…
